Follow
Elizabeth Tullis
Elizabeth Tullis
Verified email at smh.ca - Homepage
Title
Cited by
Cited by
Year
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
BW Ramsey, J Davies, NG McElvaney, E Tullis, SC Bell, P Dřevínek, ...
New England Journal of Medicine 365 (18), 1663-1672, 2011
23822011
Elexacaftor–tezacaftor–ivacaftor for cystic fibrosis with a single Phe508del allele
PG Middleton, MA Mall, P Dřevínek, LC Lands, EF McKone, D Polineni, ...
New England Journal of Medicine 381 (19), 1809-1819, 2019
15012019
Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind …
HGM Heijerman, EF McKone, DG Downey, E Van Braeckel, SM Rowe, ...
The Lancet 394 (10212), 1940-1948, 2019
9802019
Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice
C Castellani, H Cuppens, M Macek Jr, JJ Cassiman, E Kerem, P Durie, ...
Journal of cystic fibrosis 7 (3), 179-196, 2008
8642008
The future of cystic fibrosis care: a global perspective
SC Bell, MA Mall, H Gutierrez, M Macek, S Madge, JC Davies, PR Burgel, ...
The Lancet Respiratory Medicine 8 (1), 65-124, 2020
7562020
VX-445–tezacaftor–ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles
D Keating, G Marigowda, L Burr, C Daines, MA Mall, EF McKone, ...
New england journal of medicine 379 (17), 1612-1620, 2018
6202018
Guide to bone health and disease in cystic fibrosis
RM Aris, PA Merkel, LK Bachrach, DS Borowitz, MP Boyle, SL Elkin, ...
The Journal of Clinical Endocrinology & Metabolism 90 (3), 1888-1896, 2005
5522005
Tezacaftor–ivacaftor in residual-function heterozygotes with cystic fibrosis
SM Rowe, C Daines, FC Ringshausen, E Kerem, J Wilson, E Tullis, N Nair, ...
New England Journal of Medicine 377 (21), 2024-2035, 2017
4942017
Recommendations for the classification of diseases as CFTR-related disorders
C Bombieri, M Claustres, K De Boeck, N Derichs, J Dodge, E Girodon, ...
Journal of Cystic Fibrosis 10, S86-S102, 2011
4762011
Infection prevention and control guideline for cystic fibrosis: 2013 update
L Saiman, JD Siegel, JJ LiPuma, RF Brown, EA Bryson, MJ Chambers, ...
Infection Control & Hospital Epidemiology 35 (S1), s1-s67, 2014
4392014
VX-659–tezacaftor–ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles
JC Davies, SM Moskowitz, C Brown, A Horsley, MA Mall, EF McKone, ...
New england journal of medicine 379 (17), 1599-1611, 2018
3382018
Infection with Burkholderia cepacia in Cystic Fibrosis: Outcome Following Lung Transplantation
C Chaparro, J Maurer, C Gutierrez, M Krajden, C Chan, T Winton, ...
American journal of respiratory and critical care medicine 163 (1), 43-48, 2001
3142001
Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis
K de Boer, KL Vandemheen, E Tullis, S Doucette, D Fergusson, A Freitag, ...
Thorax 66 (8), 680-685, 2011
2822011
Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis
CY Ooi, R Dorfman, M Cipolli, T Gonska, C Castellani, K Keenan, ...
Gastroenterology 140 (1), 153-161, 2011
2742011
Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis
V Waters, S Stanojevic, EG Atenafu, A Lu, Y Yau, E Tullis, F Ratjen
European Respiratory Journal 40 (1), 61-66, 2012
2692012
Genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis
C Durno, M Corey, J Zielenski, E Tullis, LC Tsui, P Durie
Gastroenterology 123 (6), 1857-1864, 2002
2542002
Insulin therapy to improve BMI in cystic fibrosis–related diabetes without fasting hyperglycemia: results of the Cystic Fibrosis Related Diabetes Therapy Trial
A Moran, P Pekow, P Grover, M Zorn, B Slovis, J Pilewski, E Tullis, ...
Diabetes care 32 (10), 1783-1788, 2009
2532009
Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas
N Ahmed, M Corey, G Forstner, J Zielenski, LC Tsui, L Ellis, E Tullis, ...
Gut 52 (8), 1159-1164, 2003
2282003
Pulmonary hypertension and cardiac function in adult cystic fibrosis: role of hypoxemia
KL Fraser, DE Tullis, Z Sasson, RH Hyland, KS Thornley, PJ Hanly
Chest 115 (5), 1321-1328, 1999
2131999
Infectious complications following isolated lung transplantation
JR Maurer, DE Tullis, RF Grossman, H Vellend, TL Winton, GA Patterson
Chest 101 (4), 1056-1059, 1992
2101992
The system can't perform the operation now. Try again later.
Articles 1–20